tirzepatide and alcohol reduction Semaglutide reduce consumption in individuals with obesity Semaglutide, Tirzepatide, and Retatrutide Attenuate

Learn more about our medical advisory board here

Who responds best to CagriSema Ideal candidates: Significant obesity (BMI 30-40+) Previously plateaued on GLP-1s alone Need maximum weight loss Good GI tolerability Metabolic syndrome or diabetes Commitment to long-term use Excellent responders: Higher baseline weight (more to lose) Good adherence to protocol Combine with diet/exercise Younger patients (better metabolism) No significant medication interactions May respond less optimally: Very low starting weight (BMI 30%): Nausea (most common) Decreased appetite (intended effect) Constipation Fatigue (especially first months) Common (10-30%): Vomiting (if nausea not managed) Diarrhea (alternating with constipation) Abdominal pain/discomfort Headache Dizziness Less common ( 40 with comorbidities Insurance covers surgery Want permanent solution Don't want ongoing injections Sourcing cagrilintide and semaglutide Obtaining these peptides requires understanding current availability

Reduced Cravings and Appetite: The mechanism of action helps individuals feel fuller for longer and reduces the intensity of food cravings, making it easier to adhere to a calorie-reduced diet

Biotin: the overhyped supplement Biotin is the most marketed hair supplement, and the evidence for it is weak unless you are actually biotin deficient

Our functional medicine approach is designed to mitigate this: Resistance Training and Protein Intake : Non-negotiable components of any regimen